e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Patient health gains related to the economic effectiveness of disease management programmes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictive value of annual costs on 3-year mortality in COPD
Roberto Walter Dal Negro (Verona, Italy), Roberto W. Dal Negro, Luca Bonadiman, Paola Turco
Source:
International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Session:
Patient health gains related to the economic effectiveness of disease management programmes
Session type:
Poster Discussion
Number:
1590
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Roberto Walter Dal Negro (Verona, Italy), Roberto W. Dal Negro, Luca Bonadiman, Paola Turco. Predictive value of annual costs on 3-year mortality in COPD. Eur Respir J 2015; 46: Suppl. 59, 1590
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Late Breaking Abstract - Developing the pneumonia-optimized ratio for community-acquired pneumonia: an easy, inexpensive and accurate prognostic biomarker
Related content which might interest you:
Current and future costs of COPD in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Cost and effectiveness of 2 years integrated care intervention in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Health care workers’ knowledge about COPD and health locus of control
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Assessment of public awareness on COPD in Singapore in a one-day awareness campaign
Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products
Year: 2016
Asthma severity and medical resource utilisation
Source: Eur Respir J 2004; 23: 723-729
Year: 2004
Health care utilization and costs of asthma and COPD in the Netherlands
Source: Eur Respir J 2005; 26: Suppl. 49, 383s
Year: 2005
The relationship between social deprivation and hospital admissions with asthma
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Global asthma network survey of national asthma strategies – Where are the gaps?
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
COPD readmissions in an urban environment: Health service factors
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Cost and effectiveness of integrated care intervention on the patients with COPD
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Does registration of performance indicators improve health outcomes in COPD?
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
A disease-specific integrated care intervention (ICI) prevents hospital admission only in COPD patients with recurrent hospitalisation
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
COPD morbidity screening in high risk groups
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Current and future costs of asthma in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
The effects of socioeconomic status on health outcomes in patients with COPD
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016
Predicting risk of undiagnosed COPD in primary care: Development and validation of the TargetCOPD model
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Evidence of variation to drive quality improvement: The NHS atlas of variation in respiratory healthcare
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Investigation for asthma-related healthcare utilization and prescription of pregnant women with asthma in Korea
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept